HOME › Press Releases › Medical Aesthetics Market worth $12,581.9 Million by 2020
Medical Aesthetics Market worth $12,581.9 Million by 2020
The report “Medical Aesthetics Market by Products (Liposuction, Cellulite Reduction, Fat Reduction, Skin Tightening, Breast Implants, Botox, Dermal Fillers), Procedures (Cosmetic & Reconstructive), & End-Users (Beauty center and Home) - Global Forecast to 2020” analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the world (RoW).
Browse 135 market data tables and 47 figures spread through 216 pages and in-depth TOC on “Medical Aesthetics Market by Products (Liposuction, Cellulite Reduction, Fat Reduction, Skin Tightening, Breast Implants, Botox, Dermal Fillers), Procedures (Cosmetic & Reconstructive), & End-Users (Beauty center and Home) - Global Forecast to 2020"
Early buyers will receive 10% customization on reports.
This report studies the global medical aesthetics market over the forecast period of 2015 to 2020. The market is expected to reach $12,581.9 Million by 2020, at a CAGR of 10.8% from 2015 to 2020.
On the basis of products, the global medical aesthetics market is classified into three major segments, namely, aesthetic lasers and energy devices, aesthetic implants, and facial aesthetics. The aesthetic lasers and energy devices segment is categorized into laser resurfacing devices, body contouring devices, laser hair removal, and aesthetic ophthalmology devices. Laser resurfacing devices segment is further divided into ablative skin resurfacing devices, and non-ablative skin resurfacing devices. Body contouring devices segment is classified into liposuction devices (laser assisted liposuction devices, ultrasound assisted liposuction devices, radiofrequency assisted liposuction devices, water jet assisted liposuction devices, and other liposuction devices), cellulite reduction devices (energy based cellulite reduction devices, lipomassage devices, and mesotherapy devices), non-surgical fat reduction devices (cryolipolysis devices, laser based devices, radio frequency based devices, and ultrasound based devices), and non-surgical skin tightening devices (laser based devices, radio frequency based devices, and ultrasound based devices).
The aesthetic implants segment is classified into breast implants (silicone breast implants, saline breast implants, and cohesive semi-solid gel implants), and other implants (aesthetic dental implants, and soft tissue implants). The facial aesthetics segment is also categorized botulinum toxin (BOTOX), chemical peels, microdermabrasion, and dermal fillers (absorbable dermal fillers, and non-absorbable dermal fillers).
Based on type of procedures, the global medical aesthetics market is categorized into two major segments, namely, cosmetic procedure, and reconstructive procedure. The cosmetic procedure segment is further classified into minimally-invasive procedure and surgical procedure. Furthermore, on the basis of end user, the global medical aesthetics market is classified into clinic/beauty center (cosmetic treatment, and reconstructive treatment), and home settings.
Factors such as the increasing inclination towards minimally invasive and non-invasive aesthetic procedures, technological advancements in energy based devices and rapid growth in number of cosmetic procedures are driving the growth of the global medical aesthetics market. However, stringent safety regulations for aesthetic procedures and a social stigma associated with these treatments are restricting the growth of the global medical aesthetics market.
As of 2015, North America holds the largest share of the global medical aesthetics market, followed by Europe. However, the Asia-Pacific region is expected to grow at the highest CAGR from 2015 to 2020. This is primarily due to growing middle class disposable income, aggressive marketing by leading U.S., and an increase in awareness about aesthetics in the region.
Allergan, Inc. (U.S.) – A division of Actavis plc (Ireland), Cynosure, Inc. (U.S.), Lumenis Ltd. (Israel), Mentor Worldwide LLC (U.S.) – A business unit of Johnson & Johnson, PhotoMedex, Inc. (U.S.), Solta Medical, Inc. (U.S.) - A division of Valeant Pharmaceuticals International, Inc. (Canada), Syneron Medical, Ltd. (Israel), Galderma S.A. (Switzerland) - a wholly owned subsidiary of Nestlé S.A. and ZELTIQ Aesthetics, Inc. (U.S.) are the main players in the global medical aesthetics market.
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252